WAC 296-823-180   Additional requirements for HIV and HBV research laboratories and production facilities.  Summary.

     Your responsibility:

     To implement and enforce these additional rules in research laboratories and production facilities engaged in the culture, production, concentration, experimentation, and manipulation of HIV and HBV.

Exemption:

This section does NOT apply to clinical or diagnostic laboratories engaged solely in the analysis of blood, tissues, or organs.

Note:

Production and research facilities: Hepatitis C (HCV) is the virus involved in most cases of parenterally transmitted (bloodborne) non-A, non-B hepatitis in the United States. Most individuals who contract HCV become chronically infected (85%) and develop chronic hepatitis (70%). It is recommended that you also follow these requirements for HCV production and research facilities.

     You must:

     Prepare, review and update a biosafety manual

     WAC 296-823-18005

     Follow these special practices for the work area

     WAC 296-823-18010

     Make sure these practices for contaminated material and waste are followed

     WAC 296-823-18015

     Make sure these special practices for personal protective equipment (PPE) and other safe guards are followed

     WAC 296-823-18020

     Protect vacuum lines

     WAC 296-823-18025

     Use and handle hypodermic needles and syringes appropriately and safely

     WAC 296-823-18030

     Handle all spills and accidents properly

     WAC 296-823-18035

     Post signs

     WAC 296-823-18040

     Provide additional training for facility employees

     WAC 296-823-18045

     Furnish a sink for washing hands and a readily available eye wash facility

     WAC 296-823-18050

     Make sure these additional criteria are followed

     WAC 296-823-18055.



[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. 04-12-070, § 296-823-180, filed 6/1/04, effective 9/1/04; 03-09-110, § 296-823-180, filed 4/22/03, effective 8/1/03.]